News & Perspective

Feb 02, 2006

Feb 02, 2006

Adenovirus vaccines said to offer hope for fighting flu pandemics

(CIDRAP News) – A pair of new studies suggest that influenza vaccines based on adenoviruses, one of the causes of the common cold, may offer major advantages in the quest for protection from flu pandemics.

Jan 03, 2007

Jan 03, 2007

Report may spur quest for more versatile flu vaccines

(CIDRAP News) – California scientists report that their analysis of the medical literature has yielded data on more than 600 molecular components of influenza A viruses that trigger immune responses, findings they hope will spur the search for vaccines offering protection against multiple flu strains.

Jan 17, 2007

Jan 17, 2007

HHS funds work on dose-sparing H5N1 vaccines

(CIDRAP News) – In an effort to stretch the nation's supply of vaccines for a potential influenza pandemic, federal health officials today announced contracts totaling $132.5 million to help three companies develop dose-sparing substances, or adjuvants, to be used with H5N1 flu vaccines.

May 14, 2007

May 14, 2007

Virus sharing high on agenda as WHO meeting begins

(CIDRAP News) – The dispute over the sharing of H5N1 avian influenza samples was high on the agenda as the annual meeting of World Health Organization (WHO) member countries began today in Geneva.

May 22, 2007

May 22, 2007

WHO has draft agreement in virus-sharing dispute

(CIDRAP News) – The World Health Organization (WHO) has negotiated a preliminary agreement designed to maintain the international sharing of influenza virus samples while ensuring that developing countries can obtain pandemic flu vaccines, news services reported today.

Jun 19, 2007

Jun 19, 2007

FLU CONFERENCE COVERAGE Virus ownership claims could disrupt flu vaccine system

– TORONTO (CIDRAP News) – The continuing debate over developing countries' ability to afford pandemic-influenza vaccines has produced a disturbing complication: the possibility that Indonesia and other countries affected by H5N1 avian flu will assert legal ownership of the viral isolates on which the vaccines would be based.

Oct 25, 2007

Oct 25, 2007

THE PANDEMIC VACCINE PUZZLE Bibliography

Editor's note: This is the bibliography to a seven-part series launched October 25, 2007, investigating the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. The series puts advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

Oct 25, 2007

THE PANDEMIC VACCINE PUZZLE Part 1: Flu research: a legacy of neglect

Editor's note: This is the first in a seven-part series investigating the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. The series puts advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

Oct 29, 2007

Oct 29, 2007

THE PANDEMIC VACCINE PUZZLE Part 3: H5N1 poses major immunologic challenges

Editor's note: This is the third in a seven-part series investigating the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. The series puts promising advances in vaccine technology in perspective by illuminating the formidable barriers to producing large amounts of an effective and widely usable vaccine in a short time frame.

Oct 30, 2007

Oct 30, 2007

THE PANDEMIC VACCINE PUZZLE Part 4: The promise and problems of adjuvants

Editor's note: This is the fourth in a seven-part series investigating the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. The series puts promising advances in vaccine technology in perspective by illuminating the formidable barriers to producing large amounts of an effective and widely usable vaccine in a short time frame.

Pages

by country

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3M logo Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»